EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Efficacy and safety of adjunctive use of rifaximin in preventing radiotherapy-induced diarrhea in cancer patients: a randomized controlled trial

Menna A El-Maghraby, Noha O Mansour, Ahmed Ramadan Eldesoky, Moetaza M Soliman

Naunyn-Schmiedeberg's Archives of Pharmacology · 19.11.2026

DOI: 10.1007/s00210-026-06083-1 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 19.11.2026. Verfasst von Menna A El-Maghraby und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacy and Pharmacy Practice Department, Faculty of Pharmacy, Mansoura University, ElGomhoria Street, Mansoura, ElDakahlia, Egypt. Die Arbeit nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Bristol scaleEORTC QLQ-C30Pelvic cancerQuality of lifeStool consistency

Autor:innen und Institutionen

  • Clinical Pharmacy and Pharmacy Practice Department, Faculty of Pharmacy, Mansoura University, ElGomhoria Street, Mansoura, ElDakahlia, Egypt.
  • Pharmacy Practice Department, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.
  • Clinical Pharmacy and Pharmacy Practice Department, Faculty of Pharmacy, Mansoura University, ElGomhoria Street, Mansoura, ElDakahlia, Egypt. dr.nohamansour@gmail.com.
  • Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

Zitieren

APA

El-Maghraby, M. A., Mansour, N. O., Eldesoky, A. R., & Soliman, M. M. (2026). Efficacy and safety of adjunctive use of rifaximin in preventing radiotherapy-induced diarrhea in cancer patients: a randomized controlled trial. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-06083-1

Vancouver

El-Maghraby MA, Mansour NO, Eldesoky AR, Soliman MM. Efficacy and safety of adjunctive use of rifaximin in preventing radiotherapy-induced diarrhea in cancer patients: a randomized controlled trial. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-06083-1

BibTeX
@article{ElMaghraby2026,
  author = {El-Maghraby, Menna A and Mansour, Noha O and Eldesoky, Ahmed Ramadan and Soliman, Moetaza M},
  title = {Efficacy and safety of adjunctive use of rifaximin in preventing radiotherapy-induced diarrhea in cancer patients: a randomized controlled trial},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-026-06083-1}
}
Kostenlos starten →